Chronic necrotizing pulmonary aspergillosis as a complication of pulmonary Mycobacterium avium complex disease

Respirology

Volumn 11, Issue 6, 2006, Pages 809-813

  Kobashi, Yoshihiro ^a   Fukuda, Minoru ^a   Yoshida, Kouichiro ^a   Miyashita, Naoyuki ^a   Niki, Yoshihito ^a   Oka, Mikio ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Chronic necrotizing pulmonary aspergillosis; Pulmonary Mycobacterium avium complex disease; Radiological examination; Serological fungal examination

Indexed keywords

AMPHOTERICIN B; CLARITHROMYCIN; ETHAMBUTOL; FUNGUS ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; ITRACONAZOLE; MICAFUNGIN; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; ANTIBODY DETECTION; ARTICLE; ASPERGILLUS; BRONCHOSCOPY; CHRONIC DISEASE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFICACY; FEMALE; FOLLOW UP; FUNGUS CULTURE; HUMAN; LUNG ASPERGILLOSIS; LUNG CAVITY; LUNG INFECTION; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM INTRACELLULARE AVIUM; NONHUMAN; PRIORITY JOURNAL; SEROLOGY; SPUTUM CULTURE; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

AGED; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; CHRONIC DISEASE; FEMALE; HUMANS; IMMUNOGLOBULIN G; LUNG DISEASES, FUNGAL; MALE; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; NECROSIS; PROSPECTIVE STUDIES; TUBERCULOSIS, PULMONARY;

EID: 33750091037     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2006.00952.x     Document Type: Article

References (19)

1. Alan MS, Elizabeth AO. Aspergillus syndromes, mucormycosis and pulmonary candidiasis. In: Fisherman's Pulmonary Disease and Disorders, 3rd edn. McGraw-Hill, New York, 1998; 2265-88.
2. Kobashi Y, Yoshida K, Miyashita N, Niki Y, Matsushima T. Chronic necrotizing pulmonary aspergillosis complicated by a cavitary lesion caused by pulmonary Mycobacterium-avium complex diseases. Intern. Med. 2005; 44: 246-50.
3. American Thoracic Society. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am. J. Respir. Crit. Care Med. 1997; 156: S1-25.
4. Kim SJ, Chaparas SD. Characterization of antigens from organisms grown in completely synthetic medium. Am. Rev. Respir. Dis. 1978; 118: 547-53.
5. Wallace RJ, Brown BA, Griffith DE et al. Clarithromycin regimens for pulmonary Mycobacterium avium complex: the first 50 patients. Am. J. Respir. Crit. Care Med. 1996; 153: 1766-72.
6. Tanaka E, Kimoto T, Tsuyuguchi K et al. Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease. Am. J. Respir. Crit. Care Med. 1999; 160: 866-72.
7. Kobashi Y, Matsushima T. The effect of combined therapy according to the guidelines for the treatment of Mycobacterium avium complex pulmonary disease. Intern. Med. 2003; 42: 670-5.
8. Fraser RS, Muller NL, Coleman N et al. Diagnosis of Diseases of the Chest, 4th edn. WB Saunders, New York, 1999; 875-978.
9. Binder RE, Faling LJ, Pugatch RD et al. Chronic necrotizing pulmonary aspergillosis: a discrete clinical entity. Medicine 1982; 61: 109-24.
10. Gefter WB. The spectrum of pulmonary aspergillosis. J. Thorac. Imaging 1992; 7: 56-74.
11. Denning DW. Chronic forms of pulmonary aspergillosis. Clin. Microbiol. Infect. 2001; 7 (Suppl. 2): 25-31.
12. Massard G, Roeslin N, Wihelm JM et al. Pleuropulmonary aspergilloma: clinical spectrum and results of surgical treatment. Ann. Thorac. Surg. 1992; 54: 1159-64.
13. Chatzimichalis A, Massard G, Kassler R et al. Pleuropulmonary aspergilloma: a reappraisal. Ann. Thorac. Surg. 1998; 65: 927-9.
14. Johanston ID. Mycobacterium xenopi infection and aspergilloma. Tubercle 1988; 69: 139-43.
15. Choudat D, Horreard P, Pretet S et al. Superinfection by Aspergillus fumigatus of a pulmonary lesion caused by Mycobacterium xenopi. Tubercle 1986; 67: 71-4.
16. Sakatani M. Nontuberculous mycobacteriosis (NTM) in Japan - epidemiologic and clinical study. Kekkaku 1994; 69: 119-24 (in Japanese).
17. Kawamura S, Maesaki S, Noda T et al. Comparison between PCR and detection of antigen in sera for pulmonary aspergillosis. J. Clin. Microbiol. 1999; 37: 212-20.
18. Stevens DA, Bennett JE. Chapter 35. Antifungal Agents, Basic Principles, in the Diagnosis and Management of Infectious Diseases, 5th edn. Churchill Livingstone, New York, 2000.
19. Arathoon EG. Clinical efficacy of echinocandin antifungals. Curr. Opin. Infect. Dis. 2001; 14: 685-91.